MIP
IRMD icon

Mondrian Investment Partners’s iRadimed IRMD Stock Holding History

Mondrian Investment Partners’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-84,148
Closed -$3.89M – 125
2021
Q4 		$3.89M Sell
84,148
-52,850
-39% -$2.13M 0.08% 78
2021
Q3 		$4.6M Sell
136,998
-41,480
-23% -$1.41M 0.09% 55
2021
Q2 		$5.25M Hold
178,478
– – 0.1% 54
2021
Q1 		$4.94M Hold
178,478
– – 0.11% 67
2020
Q4 		$4.07M Buy
178,478
+26,840
+18% +$620K 0.1% 75
2020
Q3 		$3.44M Sell
151,638
-12,301
-8% -$276K 0.12% 72
2020
Q2 		$3.81M Hold
163,939
– – 0.14% 66
2020
Q1 		$3.5M Hold
163,939
– – 0.12% 62
2019
Q4 		$3.83M Buy
163,939
+20
+0% +$467 0.1% 76
2019
Q3 		$3.45M Hold
163,919
– – 0.11% 76
2019
Q2 		$3.35M Buy
163,919
+40,703
+33% +$959K 0.11% 73
2019
Q1 		$3.46M Hold
123,216
– – 0.11% 67
2018
Q4 		$3.01M Buy
123,216
+6,819
+6% +$183K 0.11% 69
2018
Q3 		$4.32M Sell
116,397
-52,466
-31% -$1.42M 0.14% 60
2018
Q2 		$3.5M Sell
168,863
-29,892
-15% -$528K 0.1% 76
2018
Q1 		$3.47M Sell
198,755
-7,792
-4% -$111K 0.09% 71
2017
Q4 		$3.13M Hold
206,547
– – 0.08% 79
2017
Q3 		$1.98M Hold
206,547
– – 0.05% 88
2017
Q2 		$1.78M Hold
206,547
– – 0.05% 88
2017
Q1 		$1.84M Buy
206,547
+70,818
+52% +$657K 0.05% 90
2016
Q4 		$1.51M Hold
135,729
– – 0.04% 92
2016
Q3 		$2.31M Buy
135,729
+57,272
+73% +$1.06M 0.06% 90
2016
Q2 		$1.71M Hold
78,457
– – 0.04% 96
2016
Q1 		$1.5M Buy
78,457
+77,490
+8,013% +$1.48M 0.03% 102
2015
Q4 		$27K Hold
967
– – ﹤0.01% 124
2015
Q3 		$24K Buy
+967
New +$23.1K ﹤0.01% 127

Other funds holding IRMD

NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
RCMC
RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
RCG
Resource Consulting Group Orlando, Florida $584M AUM 15.38% 1-Year Est. Return

Mondrian Investment Partners's IRMD Position: Q1 2022 in Review

Mondrian Investment Partners sold out of iRadimed (IRMD) in Q1 2022, closing a stake of 84,148 shares — an estimated $3.89M sold.

Mondrian Investment Partners first reported a position in IRMD in Q3 2015 and held it in 26 quarters. The position peaked at $5.25M in Q2 2021. 103 funds tracked by Wall St. Rank hold IRMD as of Q1 2022.

  • Mondrian Investment Partners reported no remaining iRadimed position as of Q1 2022 after selling out during the quarter.
  • Mondrian Investment Partners sold 84,148 iRadimed shares in Q1 2022, an estimated $3.89M.
  • Mondrian Investment Partners first reported a position in iRadimed in Q3 2015 and held it in 26 quarters.
  • Mondrian Investment Partners's iRadimed position peaked at $5.25M in Q2 2021.
  • 103 funds tracked by Wall St. Rank held iRadimed as of Q1 2022.

Based on Mondrian Investment Partners's 13F filing for Q1 2022, filed 5 May 2022.